Hemodynamic Changes in Acute Ischaemic Stroke Patients
1 other identifier
observational
50
0 countries
N/A
Brief Summary
- 1.To assess Hemodynamic changes in rtPA receiving Acute Ischaemic Stroke patients.
- 2.To assess the efficacy of rtPA in treatment of Acute Ischaemic Stroke patients.
- 3.To correlate TCD findings (post treatment) with one of standard vascular imaging in AIS (CTA or MRA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2022
CompletedStudy Start
First participant enrolled
January 10, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJanuary 19, 2022
January 1, 2022
2.9 years
January 5, 2022
January 5, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Clinical outcomes 1-neurological outcomes
assessed by NIHSS and comprising improvement (reduction of 10 points or final NIHSS ≤3) or deterioration (increase ≥4 points) in the early post-thrombolytic therapy stage
7 days
2-functional
defined by modified Rankin scale (mRS) in the late post-thrombolytic therapy (2-3 months) with good outcome been considered as mRS ≤2 ,with sICH is defined as rtPA-related intracerebral bleeding detected by CT or MRI associated with any worsening of NIHSS or death.
baseline
Secondary Outcomes (2)
Radiological outcome
24 hours
laboratory outcome
baseline
Eligibility Criteria
all cases eligible for rtPA will be recruited .
You may qualify if:
- age \> 18, both sexes, acute ischemic stroke within 4.5 hours, NIHSS (5-25)
You may not qualify if:
- Significant head trauma or prior stroke in the previous 3 months
- Symptoms suggest subarachnoid hemorrhage
- Arterial puncture at a noncompressible site in previous 7 days
- History of previous intracranial hemorrhage
- Intracranial neoplasm, AVM, or an aneurysm
- Recent intracranial or intraspinal surgery
- Elevated blood pressure (systolic greater than 185 mmHg or diastolic greater than 110 mmHg)
- Active internal bleeding
- Acute bleeding diathesis, including but not limited to
- Platelet count less than 100 000/mm\^3
- Heparin received within 48 hours resulting in abnormally elevated aPTT above the upper limit of normal
- Current use of anticoagulant with INR greater than 1.7 or PT greater than 15 seconds
- Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory tests (e.g., aPTT, INR, platelet count, ECT, TT, or appropriate factor Xa activity assays)
- Blood glucose concentration less than 50 mg/dL (2.7 mmol/L)
- Recent experience suggests that under some circumstances, with careful consideration and weighing of risk to benefit, patients may receive fibrinolytic therapy despite 1 or more relative contraindications. Consider the risk to the benefit of intravenous rtPA administration carefully if any of these relative contraindications are present:
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (7)
Arima H, Huang Y, Wang JG, Heeley E, Delcourt C, Parsons M, Li Q, Neal B, Chalmers J, Anderson C; INTERACT1 Investigators. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke. 2012 Aug;43(8):2236-8. doi: 10.1161/STROKEAHA.112.651422. Epub 2012 Jun 7.
PMID: 22678090BACKGROUNDCarter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ. Predictive variables for mortality after acute ischemic stroke. Stroke. 2007 Jun;38(6):1873-80. doi: 10.1161/STROKEAHA.106.474569. Epub 2007 Apr 19.
PMID: 17446429BACKGROUNDGerriets T, Goertler M, Stolz E, Postert T, Sliwka U, Schlachetzki F, Seidel G, Weber S, Kaps M. Feasibility and validity of transcranial duplex sonography in patients with acute stroke. J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):17-20. doi: 10.1136/jnnp.73.1.17.
PMID: 12082039BACKGROUNDMazya MV, Ahmed N, Azevedo E, Davalos A, Dorado L, Karlinski M, Lorenzano S, Neumann J, Toni D, Moreira TP; SITS Investigators. Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR. Stroke. 2018 Jul;49(7):1695-1700. doi: 10.1161/STROKEAHA.118.021485. Epub 2018 May 29.
PMID: 29844031BACKGROUNDZhang Z, Pu Y, Mi D, Liu L. Cerebral Hemodynamic Evaluation After Cerebral Recanalization Therapy for Acute Ischemic Stroke. Front Neurol. 2019 Jul 3;10:719. doi: 10.3389/fneur.2019.00719. eCollection 2019.
PMID: 31333570BACKGROUNDXu JH, He XW, Li Q, Liu JR, Zhuang MT, Huang FF, Bao GS. Higher Platelet-to-Lymphocyte Ratio Is Associated With Worse Outcomes After Intravenous Thrombolysis in Acute Ischaemic Stroke. Front Neurol. 2019 Nov 13;10:1192. doi: 10.3389/fneur.2019.01192. eCollection 2019.
PMID: 31798520BACKGROUNDWang C, Zhang Q, Ji M, Mang J, Xu Z. Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. BMC Neurol. 2021 May 11;21(1):191. doi: 10.1186/s12883-021-02222-8.
PMID: 33975565BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident
Study Record Dates
First Submitted
January 5, 2022
First Posted
January 19, 2022
Study Start
January 10, 2022
Primary Completion
December 1, 2024
Study Completion
March 1, 2025
Last Updated
January 19, 2022
Record last verified: 2022-01